Evidence map›Paper›PMID 36201547›Full record

SynthesisPLoS neglected tropical diseases2022

Transfusion-transmitted arboviruses: Update and systematic review.

Ángel Giménez-Richarte, María Isabel Ortiz de Salazar, María-Paz Giménez-Richarte, Miriam Collado, Pedro Luís Fernández, Carlos Clavijo, Laura Navarro, Cristina Arbona, Pascual Marco, Jose-Manuel Ramos-Rincon

Abstract readSystematic Review
In one paragraph

Synthesis in PLoS neglected tropical diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. A Review of the Recent Epidemiology of Zika Virus Infection.The American journal of tropical medicine and hygiene · 2025
    Review
  12. Article
  13. Article
  14. A Scoping Review of Arthropod-Borne Flavivirus Infections in Solid Organ Transplant Recipients.Transplant infectious disease : an official journal of the Transplantation Society · 2024
    Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Arboviruses and pregnancy: are the threats visible or hidden?Tropical diseases, travel medicine and vaccines · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ángel Giménez-RicharteValencian Community Blood Transfusion Center, Valencia, Spain.ORCID 0000-0002-3740-1065
María Isabel Ortiz de SalazarValencian Community Blood Transfusion Center, Valencia, Spain.
María-Paz Giménez-RicharteMedicial student, Miguel Hernandez University of Elche, Alicante, Spain.
Miriam ColladoValencian Community Blood Transfusion Center, Valencia, Spain.
Pedro Luís FernándezValencian Community Blood Transfusion Center, Valencia, Spain.
Carlos ClavijoValencian Community Blood Transfusion Center, Valencia, Spain.
Laura NavarroValencian Community Blood Transfusion Center, Valencia, Spain.
Cristina ArbonaValencian Community Blood Transfusion Center, Valencia, Spain.
Pascual MarcoService of Hematology, General- University Hospital of Alicante-ISABIAL. Alicante, Spain.
Jose-Manuel Ramos-RinconClinical Medicine Department, Miguel Hernandez University of Elche, Alicante, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe detection of the first cases of transfusion-transmitted West Nile virus in 2002 posed a new challenge for transfusion safety. Institutions like the World Health Organization have stated that blood transfusion centers need to know the epidemiology of the different emerging infectious agents and their impact on blood transfusion. The aim of the study is to review the published cases of arbovirus transmission through transfusion of blood or blood components and to analyze their main clinical and epidemiological characteristics. MATERIAL AND

methodsSystematic literature searches were conducted in MEDLINE, Embase and Scopus. Pairs of review authors selected a variety of scientific publications reporting cases of transfusion-transmitted arboviruses. Main clinical and epidemiological characteristics were reviewed of the cases described. The study protocol was registered in PROSPERO CRD42021270355.

resultsA total of 74 cases of transfusion-transmitted infections were identified from 10 arboviruses: West Nile virus (n = 42), dengue virus (n = 18), Zika virus (n = 3), yellow fever vaccine virus (n = 3), tick-borne encephalitis virus (n = 2), Japanese encephalitis virus (n = 2), Powassan virus (n = 1), St. Louis encephalitis virus (n = 1), Ross River virus (n = 1) and Colorado tick fever virus (n = 1). The blood component most commonly involved was red blood cells (N = 35, 47.3%; 95% confidence interval [CI] 35.9% to 58.7%). In 54.1% (N = 40; 95% CI: 42.7%-65.47%) of the cases, the recipient was immunosuppressed. Transmission resulted in death in 18.9% (N = 14; 95% CI: 10.0%-27.8%) of the recipients. In addition, 18 additional arboviruses were identified with a potential threat to transfusion safety. DISCUSSION: In the last 20 years, the number of published cases of transfusion-transmitted arboviruses increased notably, implicating new arboviruses. In addition, a significant number of arboviruses that may pose a threat to transfusion safety were detected. In the coming years, it is expected that transmission of arboviruses will continue to expand globally. It is therefore essential that all responsible agencies prepare for this potential threat to transfusion safety.

Indexed as

ArbovirusesArbovirus InfectionsWest Nile virusYellow Fever VaccineZika VirusZika Virus InfectionBlood TransfusionHumansYellow Fever Vaccine

Identifiers

PMID36201547
PMCPMC9578600

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.